Endodiabesity

The North West of England Endocrinology, Diabetes and Obesity Newsletter

Do we need to routinely monitor BMD in patients on bisphosphonate therapy?

Posted by Yared Demssie on 28 June, 2009

Is it helpful to routinely monitor bone mineral density in patients who are being activley treated with bisphosphonates? If so, do we need to check both hip and spine BMD or would either of the two be suficient on its own? The National Osteoporosis guideline has no recommendations on this yet but this study provides useful evidence to guide future practice.

http://www.bmj.com/cgi/content/full/338/jun23_2/b2266

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s